Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3923-3929

  Kalariti, Niki ^a   Lembessis, Peter ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Glutamate transporters; Glutamine synthetase; Ionotropic glutamate receptors; Metabotropic glutamate receptors; MG 63 cells

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLUTAMINE; IONOTROPIC RECEPTOR; MESSENGER RNA; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3B; UNCLASSIFIED DRUG; COTRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 1; ISOPROTEIN; NR1 NMDA RECEPTOR; SLC1A3 PROTEIN, HUMAN;

ARTICLE; CENTRAL NERVOUS SYSTEM; HUMAN; HUMAN CELL; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BONE TUMOR; GENETICS; METABOLISM; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEM X-AG; BONE NEOPLASMS; CELL LINE, TUMOR; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATE-AMMONIA LIGASE; HUMANS; OSTEOBLASTS; OSTEOSARCOMA; PROTEIN ISOFORMS; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS;

EID: 14944381280     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Noda M and Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991-2994, 1989.
2. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N and Suda T: Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6: 183-189, 1991.
3. Marusic A, Kalinowski JF, Harrison JR, Centrella M, Raisz LG and Lorenzo JA: Effects of transforming growth factor-beta and IL-1 alpha on prostaglandin synthesis in serum-deprived osteoblastic cells. J Immunol 146: 2633-2638, 1991.
4. McCarthy TL, Centrella M, Raisz LG and Canalis E: Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 128: 2895-2900, 1991.
5. Ralston SH, Todd D, Helfrich MH, Benjamin N and Grabowski P: Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336, 1994.
6. Kanematsu M, Ikeda K and Yamada Y: Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J Bone Miner Res 12: 1789-1796, 1997.
7. Ajubi NE, Klein-Nulend J, Alblas MJ, Burger EH and Nijweide PJ: Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am J Physiol 276: E171-178, 1999.
8. Bhangu PS, Genever PG, Spencer GJ, Grewal TS and Skerry TM: Mechanisms for regulate uptake and release of glutamate by osteoblasts. J Bone Miner Res SU190(Suppl 1): S378, 2000.
9. Genever PG and Skerry TM: Regulated glutamate exocytosis in osteoblasts. Calcif Tissue Int O-30(Suppl 1): S57, 2000.
10. Genever PG and Skerry TM: Regulated glutamate exocytosis is necessary for osteoblast differentiation and survival in vitro. J Bone Miner Res SU191(Suppl 1): S378, 2000.
11. Genever PG, Grewal TS, Bhangu PS, Preston MR, Gu Y, Publicover SJ and Skerry TM: Focal glutamate signalling in osteoblasts by regulated vesicular exocytosis. Calcif Tissue Int O-18(Suppl 1): S41, 1999.
12. Taylor AF: Osteoblastic glutamate receptor function regulates bone formation and resorption. J Musculoskel Neuron Interact 2: 285-290, 2002.
13. Kalariti N and Koutsilieris M: Glutamatergic system in bone physiology. In Vivo (in press).
14. Yoneda Y and Ogita K: Localization of 3H glutamate bindingsites in rat adrenal-medulla. Brain Res 383: 387-391, 1986.
15. Shannon HE and Sawyer BD: Glutamate receptors of the NMDA subtype in the myenteric plexus of the guinea-pig ileum. J Pharmacol Exp Ther 251: 518-523, 1989.
16. Said SI, Berisha HI and Pakbaz H: Excitotoxicity in the lung NMDA induced, nitric oxide-dependent, pulmonary-edema is attenuated by VIP and by inhibitors of poly(adp-ribose) polymerase. Proc Natl Acad Sci USA 93: 4688-4692, 1996.
17. Inagaki N, Kuromi H, Gonoi T, Okamoto Y, Ishida H, Seino Y, Kaneko T, Iwanaga T and Seino S: Expression and role of ionotropic glutamate receptors in pancreatic-islet cells. FASEB J 9: 686-691, 1995.
18. Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA and Skerry TM: Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 20: 199-205, 1997.
19. Skerry TM and Genever PG: Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 22: 174-181, 2001.
20. Taylor AF: Functional osteoblastic ionotropic glutamate receptors are a prerequisite for bone formation. J Musculoskel Neuron Interact 2: 415-422, 2002.
21. Peet NM, Grabowski PS, Laketic LI and Skerry TM: The glutamate receptor antagonist MK801 modulates bone resorption by a mechanism predominantly involving osteoclast differentiation. FASEB J 13: 2179-2185, 1999.
22. Monaghan DT, Bridges RJ and Cotman CW: The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365-402, 1989.
23. Hollmann M and Heinemann S: Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108, 1994.
24. Rosenmund C, Stern-Bach Y and Stevens CF: The tetrameric structure of a glutamate receptor channel. Science 280: 1596-1599, 1998.
25. Hawkins LM, Chazot PL and Stephensen FA: Biochemical evidence for the co-association of three N-methyl-D-aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J Biol Chem 274: 27211-27218, 1999.
26. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N and Nakanishi S: Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31-37, 1991.
27. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M and Nakanishi S: Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268: 2836-2843, 1993.
28. Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K and Mishina M: Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 557: 70-74, 1992.
29. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M and Mishina M: Molecular diversity of the NMDA receptor channel. Nature 358: 36-41, 1992.
30. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B and Seeburg PH: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221, 1992.
31. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA and Nakanishi N: Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381, 1998.
32. Tanabe Y, Masu M, Ishii T, Shigemoto R and Nakanishi S: A family of metabotropic glutamate receptors. Neuron 8: 169-179, 1992.
33. Masu M, Tanabe Y, Tsuchida K, Shigemoto R and Nakanishi S: Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760-765, 1991.
34. Storck T, Schulte S, Hofmann K and Stoffel W: Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89: 10955-10959, 1992.
35. Tanaka K: Cloning and expression of a glutamate transporter from mouse brain. Neurosci Lett 759: 183-186, 1993.
36. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E and Kanner BI: Cloning and expression of a rat brain L-glutamate transporter. Nature 560: 464-467, 1992.
37. Kanai Y and Hediger MA: Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 560: 467-471, 1992
38. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP and Amara SG: An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375: 599-603, 1995.
39. Arriza JL, Eliasof S, Kavanaugh MP and Amara SG: Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 8: 4155-4160, 1997.
40. Meister A: Catalytic mechanism of glutamine synthetase: Overview of glutamine metabolism. In: The Glutamine Metabolism, Enzymology, and Regulation (Mora J and Palacios R, eds). New York, NY, USA, Academic Press. 1980, pp 1-40.
41. Meister A: Glutamine synthetase from mammalian tissues. In: Methods in Enzymology (Colowick SP, Kaplan NO and Meister A, eds). New York, NY, USA, Academic Press. 1985, vol. 113 pp 185-199.
42. Wang Y, Kudoh J, Kubota R, Asakawa S, Minoshima S and Shimizu N: Chromosomal mapping of a family of human glutamine synthetase genes: functional gene (GLUL) on 1q25, pseudogene (GLULP) on 9p13, and three related genes (GLULL1, GLULL2, GLULL3) on 5q33, 11p15, and 11q24. Genomics 37: 195-199, 1996.
43. Goumenou AG, Vassiliadis S, Matalliotakis IM, Koumantakis EG, Lembessis P and Koutsilieris M: Mutation analysis of BrCA1, BrCA2, and p53 versus soluble HLA class I and class II in a case of familial endometriosis. Fertil Steril 79: 445-448, 2003.
44. Itzstein C, Cheynel H, Burt-Pichat B, Merle B, Espinosa L, Delmas PD and Chenu C: Molecular identification of NMDA glutamate receptors expressed in bone cells. J Cell Biochem 82: 134-144, 2001.
45. Chenu C: Glutamatergic regulation of bone resorption. J Musculoskel Neuron Interact 2: 423-431, 2002.
46. Skerry TM: Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton. J Bone Miner Metab 77: 66-70, 1999.
47. Birch MA, Genever PG, Laketic-Ljubojevic I, Patton AJ, Peet NM and Skerry TM: Glutamate receptor activation is necessary for bone formation in vitro. J Bone Miner Res 12: 010, 1997.
48. Hinoi E, Fujimori S and Yoneda Y: Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. Faseb J 17: 1532-1534, 2003.
49. Chenu C, Serre CM, Raynal C, Burt-Pichat B and Delmas PD: Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22: 295-299, 1998.
50. Itzstein C, Espinosa L, Delmas PD and Chenu C: Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resorption. Biochem Biophys Res Commun 268: 201-209, 2000.
51. Kohr G and Seeburg PH: Subtype-specific regulation of recombinant NMDA receptor channels by protein tyrosine kinases of the Src family. J Physiol 492: 445-452, 1996.
52. Boyce BF, Yoneda T, Lowe C, Soriano P and Mundy GR: Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90: 1622-1627, 1992.
53. Hinoi E, Fujimori S, Nakamura Y and Yoneda Y: Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem Biophys Res Commun 281: 341-346, 2001.
54. Gu Y and Publicover SJ: Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross-talk with N-methyl-D-aspartate receptors. J Biol Chem 275: 34252-34259, 2000.
55. Olkku A, Bodine PVN, Linnnala-Kankkunen A and Mahonen A: Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. Bone 34: 320-329, 2004.
56. Mason DJ and Hugget JF: Glutamate transporters in bone. J Musculoskel Neuron Interact 2: 406-414, 2002.